Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Nephrology and internal intensive Care
Eva Schrezenmeier has not added Biography.
If you are Eva Schrezenmeier and would like to personalize this page please email our Author Liaison for assistance.
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling.
Biochemical pharmacology Dec, 2012 | Pubmed ID: 23022225
Moderate correlations of in vitro versus in vivo pharmacokinetics questioning the need of early microsomal stability testing.
Pharmacology , 2012 | Pubmed ID: 23037500
The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein.
International journal of molecular medicine Apr, 2014 | Pubmed ID: 24424509
Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 12, 2016 | Pubmed ID: 27369852
Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany.
Transplantation proceedings Dec, 2017 | Pubmed ID: 29198659
Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.
Journal of the American Society of Nephrology : JASN 03, 2018 | Pubmed ID: 29326157
Assessment of the Kidney Donor Profile Index in a European cohort.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 08, 2018 | Pubmed ID: 29617898
Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.
Therapeutic drug monitoring 02, 2019 | Pubmed ID: 30422962
Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations.
Current opinion in rheumatology 03, 2019 | Pubmed ID: 30540579
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.
BMC nephrology 02, 2019 | Pubmed ID: 30717681
Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.
Frontiers in immunology , 2019 | Pubmed ID: 30740098
Diagnostic Utility of Exome Sequencing for Kidney Disease.
The New England journal of medicine 05, 2019 | Pubmed ID: 31116936
EZH2 Inhibition in B Cell Subsets: Comment on the Article by Rohraff et al.
Arthritis & rheumatology (Hoboken, N.J.) 02, 2020 | Pubmed ID: 31599494
Mutations Implicate RAB11-Dependent Vesicular Trafficking in the Pathogenesis of Nephrotic Syndrome.
Journal of the American Society of Nephrology : JASN 12, 2019 | Pubmed ID: 31732614
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.
Nature reviews. Rheumatology 03, 2020 | Pubmed ID: 32034323
Role for antimalarials in the management of COVID-19.
Current opinion in rheumatology 09, 2020 | Pubmed ID: 32675717
The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single-center cohort study.
Transplant international : official journal of the European Society for Organ Transplantation Feb, 2021 | Pubmed ID: 33205460
Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients.
Journal of clinical medicine Dec, 2020 | Pubmed ID: 33383877
What happens after graft loss? A large, long-term, single-center observation.
Transplant international : official journal of the European Society for Organ Transplantation Apr, 2021 | Pubmed ID: 33527467
The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation.
Genetics in medicine : official journal of the American College of Medical Genetics Mar, 2021 | Pubmed ID: 33712733
Deep Phenotyping of CD11c B Cells in Systemic Autoimmunity and Controls.
Frontiers in immunology , 2021 | Pubmed ID: 33777025
Charité Universitätsmedizin Berlin
Wiebke Duettmann1,
Marcel G. Naik1,
Danilo Schmidt2,
Matthias Pfefferkorn1,
Matthias Kurz1,
Verena Graf1,
Andrea Kreichgauer3,
Severin Hoegl4,
Max Haenska4,
Tim Gielsdorf1,
Tillmann Breitenstein1,
Bilgin Osmanodja1,
Petra Glander1,
Jannis Bakker1,
Manuel Mayrdorfer1,
Carolin J. Gethmann1,
Friederike Bachmann1,
Mira Choi1,
Eva Schrezenmeier1,
Bianca Zukunft1,
Fabian Halleck1,
Klemens Budde1
1Department of Nephrology and internal intensive Care, Charité Universitätsmedizin Berlin,
2IT Department, Charité Universitätsmedizin Berlin,
3Department of Neurology, Charité Universitätsmedizin Berlin,
4, comjoodoc business solutions GmbH
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.